Kiadis Pharma NV (FRA:K3P) Price-to-Tangible-Book : (As of May. 25, 2024)

Kiadis Pharma NV Price-to-Tangible-Book Chart

Kiadis Pharma NV Annual Data
	Trend	Dec12	Dec13	Dec14	Dec15	Dec16	Dec17	Dec18	Dec19	Dec20
Price-to-Tangible-Book		Get a 7-Day Free Trial				-	44.57	5.50	-	-

Kiadis Pharma NV Semi-Annual Data
	Dec12	Dec13	Jun14	Dec14	Jun15	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20
Price-to-Tangible-Book	Get a 7-Day Free Trial											5.50	15.67	-	-	-

Competitive Comparison of Kiadis Pharma NV's Price-to-Tangible-Book

For the Biotechnology subindustry, Kiadis Pharma NV's Price-to-Tangible-Book, along with its competitors' market caps and Price-to-Tangible-Book data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Kiadis Pharma NV's Price-to-Tangible-Book Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Kiadis Pharma NV's Price-to-Tangible-Book distribution charts can be found below:

* The bar in red indicates where Kiadis Pharma NV's Price-to-Tangible-Book falls into.

Kiadis Pharma NV Price-to-Tangible-Book Calculation

Kiadis Pharma NV's price-to-tangible-book ratio for today is calculated as:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

It can also be calculated from the numbers for the whole company:

A closely related ratio is called PB Ratio. The difference between Price-to-Tangible-Book Ratio and PB Ratio is that book value other than intangibles are used in the calculation.

Be Aware

Some businesses have very light assets, such as software companies or insurance agencies. The Price-to-Book Ratio does not work well for these companies. Some companies even have negative equity, so the Price-to-Book Ratio cannot be applied to them.

Kiadis Pharma NV Price-to-Tangible-Book Related Terms

Thank you for viewing the detailed overview of Kiadis Pharma NV's Price-to-Tangible-Book provided by GuruFocus.com. Please click on the following links to see related term pages.

Kiadis Pharma NV (FRA:K3P) Business Description